Miniziston is a combination birth control pills with low estrogen and progestogen. Designed for indoor reception.
The main active ingredients: ethinyl estradiol and levonorgestrel.
The drug prevents ovulation, the formation and maturation of the egg in the follicle, cyclic changes in the endometrium.
It is worth noting that Miniziston, reviews confirm it almost does not prevent menstrualnopodobnoe cyclic bleeding.
Dosage form Minizistona - beige pills.
- hormonal contraception;
- functional disorders of the menstrual cycle.
According to the instructions, Miniziston has many contraindications, so it can be taken only on doctor's advice.
It is strictly forbidden at the reception Minizistona:
- liver tumors;
- hormone dependent tumors of the uterus or mammary glands;
- severe hepatic impairment;
- idiopathic jaundice or pruritus during the preceding pregnancy;
- severe disorders of lipid metabolism;
- severe diabetes;
- existing or transferred thromboembolic diseases, thromboses of veins and arteries;
- severe cardiovascular diseases;
- sickle cell anemia;
- severe hypertension;
- Rotor syndrome;
- Dubin-Johnson syndrome.
Instructions Minizistona: methods of use
Instruction Minizistonu assumes the same dosing schedule as and similar hormonal contraceptives. Within 21 days of medication you need to take 1 tablet a day. After this time you need to take a break for a week, during which there must come a typical menstrual bleeding.
First the drug, according to the instructions Minizistonu should coincide with the first day of the menstrual cycle.
To maintain a constant level of hormone in the blood plasma techniques Minizistona spacing should not exceed 36 hours, and generally recommended to take it every 22-26 hours.
When using Minizistona for the treatment of various disorders of the menstrual cycle dosing regimen can be set individually, taking into account evidence.
At reception Minizistona, reviews women confirm this, particularly in the period of adaptation to the drug, there may be some side effects such as depression, headache, breast tenderness, nausea and diarrhea.
In some cases during long-term use may lead to poor tolerability of contact lenses and the appearance of brown spots on the skin.
Conditions and terms
Miniziston should be stored no longer than 3 years in a dry place inaccessible to children.